OO3

5-Aminosalicylic acid

Created:2022-09-15
Last modified:  2026-06-17
Find related ligands:
Help
Chemical Details
Formal Charge0
Atom Count18
Chiral Atom Count0
Bond Count18
Aromatic Bond Count6
2D diagram of OO3
Chemical Component Summary
Name5-Aminosalicylic acid
Synonyms5-azanyl-2-oxidanyl-benzoic acid
Systematic Name (OpenEye OEToolkits)5-azanyl-2-oxidanyl-benzoic acid
FormulaC7 H7 N O3
Molecular Weight153.135
TypeNON-POLYMER
Chemical Descriptors
TypeProgramVersionDescriptor
SMILESCACTVS3.385Nc1ccc(O)c(c1)C(O)=O
SMILESOpenEye OEToolkits3.1.0.0c1cc(c(cc1N)C(=O)O)O
Canonical SMILESCACTVS3.385 Nc1ccc(O)c(c1)C(O)=O
Canonical SMILESOpenEye OEToolkits3.1.0.0 c1cc(c(cc1N)C(=O)O)O
InChIInChI1.06 InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)
InChIKeyInChI1.06 KBOPZPXVLCULAV-UHFFFAOYSA-N
Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank IDDB00244 
NameMesalazine
Groups
  • investigational
  • approved
DescriptionAn anti-inflammatory agent, structurally related to the salicylates and non-steroidal anti-inflammatory drugs like acetylsalicylic acid, which is active in inflammatory bowel disease [A174022]. Although demonstrably effective in treating and maintaining remission for ulcerative colitis, mesalazine has historically faced a number of issues regarding its lack of stability as a pharmaceutical agent [A174019]. Throughout the late seventies and the eighties, important research initiatives developed stable mesalazine formulations like the eudragit-S coating of Asacol brand mesalazine and the Pentasa brand's encapsulation of mesalazine within microgranules [A174019]. In the present day, contemporary research regarding novel methods to stabilize mesalazine continues and interest in the agent's capacity to decrease inflammatory activity and subsequently potentially reduce the risk of colorectal cancer in conditions like ulcerative colitis is maintained.[A174019,A174022]
Synonyms
  • Mesalazinum
  • Mésalazine
  • m-Aminosalicylic acid
  • 5-aminosalicylic acid
  • Mesalazine
Brand Names
  • Pentasa Extended-release Tablets 250mg
  • Asacol
  • Ntp-5-aminosalicylic Acid
  • Apriso
  • Lialda
IndicationMesalazine is indicated for the treatment of mildly to moderately active ulcerative colitis in adults and patients 5 years or older.[L36280,L36275]. Mesalazine is also indicated for the maintenance of remission of ulcerative colitis in adults and maintenance of remission of Crohn's ileocolitis.[L44196,L5101]
Categories
  • Agents causing hyperkalemia
  • Agents that produce hypertension
  • Aminosalicylate
  • Aminosalicylic Acids
  • Analgesics
ATC-CodeA07EC02
CAS number89-57-6

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Prostaglandin G/H synthase 2MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFY...unknowninhibitor
Prostaglandin G/H synthase 1MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFG...unknowninhibitor
Polyunsaturated fatty acid 5-lipoxygenaseMPSYTVTVATGSQWFAGTDDYIYLSLVGSAGCSEKHLLDKPFYNDFERGA...unknowninhibitor
Peroxisome proliferator-activated receptor gammaMGETLGDSPIDPESDSFTDTLSANISQEMTMVDTEMPFWPTNFGISSVDL...unknownagonist
Inhibitor of nuclear factor kappa-B kinase subunit alphaMERPPGLRPGAGGPWEMRERLGTGGFGNVCLYQHRELDLKIAIKSCRLEL...unknowninhibitor
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682